Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
Quick Stats
Jan 30, 202652.9
AI Score
HOLD1.85
Volume Ratio
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
LIXT Stock Summary
Last updated Jan 30, 2026
LIXT is currently trading at $3.72, positioned above its 200-day moving average of $3.4, indicating a long-term uptrend. The stock has a 52-week range of $0.64 to $6.26.
Technical Analysis: The 50-day moving average stands at $3.91, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 51.694, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.028, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LIXT at 52.9/100 with a HOLD recommendation.
LIXT (Lixte Biotechnology Holdings, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 51.694 |
| CMF (20) | -0.028 |
| ROC (10) | 9.091 |
| ADX (14) | 20.134 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.084 |
| AROONOSC (14) | 42.857 |
| WILLAMS %R (14) | -25.217 |
| MFI (14) | 51.473 |
LIXT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LIXT Price vs Max Options Open Interest
LIXT Max Change In Options Open Interest
LIXT Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LIXT Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LIXT Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LIXT Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lixte Biotechnology Holdings, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LIXT Moving Averages Analysis
Lixte Biotechnology Holdings, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Lixte Biotechnology Holdings, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
LIXT (Lixte Biotechnology Holdings, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.46 |
| 20 | 3.54 |
| 30 | 3.7 |
| 50 | 3.91 |
| 100 | 4.33 |
| 200 | 3.4 |
LIXT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 32.3 million |
| Earnings/Share ($) | -1.19 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |